Non-Segmental Vitiligo
23 clinical trials · Condition
◉ Watch Non-Segmental Vitiligo
| Record | Firm | Date |
|---|---|---|
| Study to Evaluate Adverse Events and Change in Disease Activity With Oral Tablets of Upadacitinib in Adult Participants With Non-Segmental Vitiligo (NCT04927975) | AbbVie | 2021-06-30 |
| Latanoprost Plus NB-UVB Versus Each Alone in Non-segmental Vitiligo: Clinical and Laboratory Evaluation (NCT04811326) | Shaimaa Fawzy Abdel-rady Abdel-latif | 2021-01-13 |
| Efficacy and Safety of AS012 in Subjects With Non-segmental Vitiligo (NCT04487860) | Ache Laboratorios Farmaceuticos S.A. | 2021-01-13 |
| Topical Ruxolitinib Evaluation in Vitiligo Study 2 (TRuE-V2) (NCT04057573) | Incyte Corporation | 2019-10-03 |
| The Evaluation of Vitiligous Lesions Repigmentation After Topical Administration of Methotrexate in Patients With Active Vitiligo (NCT04942860) | Nicolaus Copernicus University | 2019-10-01 |
| Topical Ruxolitinib Evaluation in Vitiligo Study 1 (TRuE-V1) (NCT04052425) | Incyte Corporation | 2019-09-20 |
| ReNovaCell in Non-segmental Vitiligo (NCT03022019) | Netherlands Institute for Pigment Disorders | 2016-12-01 |
Track Non-Segmental Vitiligo automatically
Every clearance here is in the API, with alerts when new ones post.